Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HIKAL. vs DISHMAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    HIKAL. DISHMAN PHARMA HIKAL./
DISHMAN PHARMA
 
P/E (TTM) x 32.6 30.0 108.7% View Chart
P/BV x 3.5 3.3 105.5% View Chart
Dividend Yield % 0.7 0.7 112.6%  

Financials

 HIKAL.   DISHMAN PHARMA
EQUITY SHARE DATA
    HIKAL.
Mar-21
DISHMAN PHARMA
Mar-16
HIKAL./
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs204374 54.6%   
Low Rs67129 52.1%   
Sales per share (Unadj.) Rs139.5197.0 70.8%  
Earnings per share (Unadj.) Rs10.821.2 51.0%  
Cash flow per share (Unadj.) Rs17.734.7 51.0%  
Dividends per share (Unadj.) Rs2.002.00 100.0%  
Avg Dividend yield %1.50.8 185.4%  
Book value per share (Unadj.) Rs75.7179.9 42.1%  
Shares outstanding (eoy) m123.3080.70 152.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.01.3 76.2%   
Avg P/E ratio x12.611.9 105.9%  
P/CF ratio (eoy) x7.77.3 105.7%  
Price / Book Value ratio x1.81.4 128.2%  
Dividend payout %18.59.4 196.2%   
Avg Mkt Cap Rs m16,73820,307 82.4%   
No. of employees `000NANA-   
Total wages/salary Rs m1,6435,355 30.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m17,20415,898 108.2%  
Other income Rs m50265 18.8%   
Total revenues Rs m17,25416,163 106.8%   
Gross profit Rs m3,2294,103 78.7%  
Depreciation Rs m8521,091 78.2%   
Interest Rs m362944 38.3%   
Profit before tax Rs m2,0642,334 88.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m733624 117.5%   
Profit after tax Rs m1,3311,710 77.9%  
Gross profit margin %18.825.8 72.7%  
Effective tax rate %35.526.7 132.9%   
Net profit margin %7.710.8 71.9%  
BALANCE SHEET DATA
Current assets Rs m9,25111,018 84.0%   
Current liabilities Rs m7,0339,517 73.9%   
Net working cap to sales %12.99.4 136.6%  
Current ratio x1.31.2 113.6%  
Inventory Days Days2657 46.1%  
Debtors Days Days1033 2,945.3%  
Net fixed assets Rs m10,90618,787 58.0%   
Share capital Rs m247161 152.8%   
"Free" reserves Rs m9,08714,354 63.3%   
Net worth Rs m9,33414,516 64.3%   
Long term debt Rs m2,6294,189 62.8%   
Total assets Rs m20,15729,805 67.6%  
Interest coverage x6.73.5 193.1%   
Debt to equity ratio x0.30.3 97.6%  
Sales to assets ratio x0.90.5 160.0%   
Return on assets %8.48.9 94.3%  
Return on equity %14.311.8 121.1%  
Return on capital %20.317.5 115.7%  
Exports to sales %68.724.9 276.1%   
Imports to sales %26.93.7 718.8%   
Exports (fob) Rs m11,8233,956 298.8%   
Imports (cif) Rs m4,623594 777.9%   
Fx inflow Rs m11,8234,952 238.8%   
Fx outflow Rs m4,623697 663.6%   
Net fx Rs m7,2004,255 169.2%   
CASH FLOW
From Operations Rs m2,2902,786 82.2%  
From Investments Rs m-1,562-1,529 102.2%  
From Financial Activity Rs m-969-941 102.9%  
Net Cashflow Rs m-240317 -76.0%  

Share Holding

Indian Promoters % 68.8 61.4 112.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.8 23.0 20.9%  
FIIs % 3.9 12.0 32.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.2 38.6 80.9%  
Shareholders   79,105 52,291 151.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare HIKAL. With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    CIPLA    AUROBINDO PHARMA    



Today's Market

Sensex Zooms 515 Points, Nifty Ends Above 17,600; Financial and IT Stocks Rally(Closing)

Indian share markets rose today tracking the rally in US stocks after softer-than-expected US inflation data stoked speculation the Federal Reserve could pivot to a shallower pace of interest-rate hikes.